Per the brand's own landing page, treat the 10,978 and 10,257 figures as brand-reported and unaudited - not confirmed by any outside platform
#ClinicalTrials #PharmaceuticalResearch #DrugDevelopment #LifeSciences #HealthcareInnovation #Biopharma #MedicalResearch #GlobalHealth #HealthcareIndustry #MarketInsights #PharmaGrowth #ResearchAndDevelopment To view or add a comment, sign in As of late March 2026, major developments for semaglutide include the launch of affordable generic versions in India by multiple pharmaceutical companies following patent expiry
Slows Gastric Emptying GLP-1 medications slow the rate at which the stomach empties, suppressing appetite and leading to subsequent weight loss
You can get a GLP-1 prescription from an app in about the time it takes to order lunch
The patent landscape reflects intense focus on permeation enhancers, solid oral compositions, and buccal or sublingual alternatives to injection [7, 8, 9]